Diabetes Mellitus Type 1 clinical trials

Explore recruiting diabetes mellitus type 1 clinical trials.

Recruiting diabetes mellitus type 1 studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diabetes Mellitus Type 1 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-264 in Subjects With Type 1 Diabetes Mellitus

Netherlands, Germany, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Glucagon enhanced insulin absorption in Diabetes Mellitus type 1

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

The effect of transdermal 17-β-estradiol/progesterone supplementation on glucose regulation in peri- and postmenopausal women with type 1 and type 2 diabetes

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Desferal administration to improve the impaired reaction to hypoxia in diabetes (DESIRED) - A randomised, double-blind, placebo-controlled, cross-over study.

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

A study to see the effect of NNC0194-0499 alone or in combination with semaglutide on blood sugar control in people living with type 1 diabetes.

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A study to test how insulin NNC0471-0119 H works in the body in participants with type 1 diabetes when given by an insulin pump.

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Diabetes Mellitus Type 1 trials by city

Diabetes Mellitus Type 1 in Toronto Diabetes Mellitus Type 1 in Vancouver Diabetes Mellitus Type 1 in Montreal Diabetes Mellitus Type 1 in Calgary Diabetes Mellitus Type 1 in Edmonton Diabetes Mellitus Type 1 in Ottawa Diabetes Mellitus Type 1 in Winnipeg Diabetes Mellitus Type 1 in Quebec City Diabetes Mellitus Type 1 in Hamilton Diabetes Mellitus Type 1 in Kitchener Diabetes Mellitus Type 1 in London Diabetes Mellitus Type 1 in Halifax Diabetes Mellitus Type 1 in New York Diabetes Mellitus Type 1 in Los Angeles Diabetes Mellitus Type 1 in Chicago Diabetes Mellitus Type 1 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease